Article
Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels.
Scientific reports - 27 Jun 2023
Jongbloed Elisabeth M, Jansen Maurice P H M, de Weerd Vanja, Helmijr Jean A, Beaufort Corine M, Reinders Marcel J T, van Marion Ronald, van IJcken Wilfred F J, Sonke Gabe S, Konings Inge R, Jager Agnes, Martens John W M, Wilting Saskia M, Makrodimitris Stavros
Abstract excerpt
Next generation sequencing of cell-free DNA (cfDNA) is a promising method for treatment monitoring and therapy selection in metastatic breast cancer (MBC). However, distinguishing tumor-specific variants from sequencing artefacts and germline variation with low false discovery rate is challenging when using large targeted sequencing panels covering many tumor suppressor genes. To address this, we built a machine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
